Cognition Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:CGTX) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Cash from operating activities -6.85 M-8.38 M-9.88 M-5.62 M-5.65 M -29.53 M Cash from investing activities -58 K-30 K——— — Cash from financing activities 329 K11.38 M1.3 M752 K33.92 M 47.35 M Free cash flow -6.85 M-8.38 M-9.88 M-5.62 M-5.65 M -29.53 M

Новости

Cognition Therapeutics bespricht mit FDA nächste Studienphase für Demenz-Medikament

Cognition Therapeutics holds FDA meeting on Lewy bodies dementia drug

Cognition Therapeutics meldet positive Phase-2-Studienergebnisse für DLB-Medikament

Cognition’s DLB drug shows positive results in phase 2 trial

Cognition Therapeutics schließt Patientenrekrutierung für DLB-Studienprogramm ab

Cognition Therapeutics completes enrollment in expanded access program

Cognition Therapeutics skizziert Pläne für Phase-3-Studie mit Alzheimer-Wirkstoff

Cognition Therapeutics outlines Phase 3 plans for Alzheimer’s drug

Cognition Therapeutics: A High-Stakes Bet On A Single Drug - Why I Hold (NASDAQ:CGTX)

Alzheimer-Studie: Cognition Therapeutics erreicht Rekrutierungsziel

Cognition Therapeutics completes enrollment in Alzheimer’s drug trial

Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?